Study of vitamin K2-7 (MK-7) in patients with diabetic peripheral neuropathy and/ or megaloblastic anaemia
Phase 4
Completed
- Conditions
- Health Condition 1: null- Neuropathy occuring because of Megaloblastic Anaemia, Type 2 Diabetes Mellitus
- Registration Number
- CTRI/2012/08/002930
- Lead Sponsor
- Viridis BioPharma Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Adult male and non-pregnant female patients of the age group 18-60 years
2.Confirmed diagnosis of vitamin B12 deficiency and/or Diabetes Mellitus including pre-diabetics as per WHO criteria
3.Clinical and/or laboratory evidence of peripheral neuropathy
4.No history of drug allergy or significant vitamin K intake
5.Willing to give informed consent
Exclusion Criteria
1.Any major systemic illness.
2.Glycosylated hemoglobin more than 9 and Sugar Fasting more than 250 mg%
3.Patient who are on anti coagulant drug
4.Patient who are on any concomitant medication of neurotoxic or anti-peresthetic drug
5.Patient with sever acute illness
6.Person who are addicted to alcohol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method